Pharming the immune response, milking the mouse Sean Henahan Newsletter Article 28 February 2013 Pages: 3 - 3
‘Proof of principle’ established for cancer immunotherapy Newsletter Article 28 February 2013 Pages: 4 - 4
Greater recognition of mental health problems in women needed Newsletter Article 28 February 2013 Pages: 6 - 6
Screening/surgery not cost-effective in those free of stroke symptoms Newsletter Article 28 February 2013 Pages: 6 - 6
The practical impact of pharmacoeconomics - 3 perspectives Tracey Langsdale Newsletter Article 28 February 2013 Pages: 7 - 8
Interleukin 12 could be a new option for cryptococcosis Newsletter Article 28 February 2013 Pages: 9 - 9
Worthwhile improvement with ampligen in chronic fatigue syndrome Newsletter Article 28 February 2013 Pages: 9 - 9
SM-8849 shows broad spectrum of antiarthritic potential Newsletter Article 28 February 2013 Pages: 10 - 10
Immunotoxin promising for untreatable adult T cell leukaemia Newsletter Article 28 February 2013 Pages: 11 - 11
‘Compelling evidence’ for anti-HIV effects of foscarnet Newsletter Article 28 February 2013 Pages: 12 - 12
Support for pravastatin rings loud and clear Gill Higgins Newsletter Article 28 February 2013 Pages: 13 - 13
Transdermal nicotine in ulcerative colitis - evidence patchy? Newsletter Article 28 February 2013 Pages: 14 - 14
Anticonvulsant may be bipolar disorder treatment in disguise Newsletter Article 28 February 2013 Pages: 15 - 15
News from the American College of Cardiology 43rd Annual Scientific Session Newsletter Article 28 February 2013 Pages: 16 - 17
Long-term acid suppressant therapy in general practice Newsletter Article 28 February 2013 Pages: 18 - 18
Lenograstim accelerates neutrophil recovery in BMT Newsletter Article 28 February 2013 Pages: 18 - 18
New York study confirms European tretinoin results Newsletter Article 28 February 2013 Pages: 19 - 19
Tamoxifen and low-fat diet in breast cancer treatment Newsletter Article 28 February 2013 Pages: 20 - 20
